SanoGene Therapeutics Inc.
This article was originally published in Start Up
Executive Summary
SanoGene Therapeutics thinks it will be able to enhance outcomes for glioblastoma patients by following the unavoidable brain surgery with an injection of targeted plasmids containing short sequences of RNA.